Treatment for Depression

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Depression+6 More
Eligibility
< 18
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test an 8-session intervention for children with asthma and anxiety or depression. The goal is to see if it is feasible and acceptable.

Eligible Conditions
  • Depression
  • Childhood Depression
  • Asthma
  • Anxiety

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 8 Secondary · Reporting Duration: From baseline to post-intervention (8-weeks) and at 16 weeks post-intervention.

8 weeks
Acceptability of the Intervention - for the Child Participants
Acceptability of the Intervention - for the Parent/Caregiver Participants
Acceptability related to the Intervention
8-weeks
Feasibility of the Intervention
Week 16
Anxiety Measure (Screen for Child Anxiety Related Disorders [SCARED]) - Child
Asthma Control Test - Combined Child and Parent/Caregiver
Asthma Illness Representations - Child Version (AIRS-C)
Depression Measure (Patient-Reported Outcomes Measurement Information System [PROMIS]- Child Depression Short Form)
Peak Flow - Child
Pediatric Asthma Quality of Life Questionnaire (PAQLQ) - Child
Pediatric Symptom Checklist - completed by the Parent/Caregiver
Week 16
Asthma Management Self-Efficacy - Child

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

14 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: from baseline to post-intervention (8-weeks) and at 16 weeks post-intervention.

Who is running the clinical trial?

Sigma Theta Tau InternationalOTHER
2 Previous Clinical Trials
118 Total Patients Enrolled
University of North Carolina, GreensboroLead Sponsor
26 Previous Clinical Trials
16,099 Total Patients Enrolled
4 Trials studying Depression
421 Patients Enrolled for Depression
Colleen McGovern, PhDPrincipal Investigator - University of North Carolina, Greensboro
University of North Carolina, Greensboro

Eligibility Criteria

Age < 18 · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
The caregiver is responsible for the day-to-day management of the child's asthma and should work together with the other parent to make sure the child is staying healthy.
If your child has been diagnosed with asthma or reactive airway and has been prescribed a controller medication, then it is important to follow the instructions for use carefully
The child screened positive for elevated anxiety or depressive symptoms when they enrolled.
The parent/caregiver can understand and answer the survey questions in English

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 16th, 2021

Last Reviewed: October 24th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.